Current Odds
Outcome
Market Prob
Spread
Before 2033
$7K volume
40.0%
—
Live marketEnds Jan 1, 2033 (6y 272d)Updated just now
Will the FDA approve a cure for Type 1 diabetes before 2033?
Live prediction market odds for "Will the FDA approve a cure for Type 1 diabetes before 2033?". Before 2033 is leading at 40.0%. Total volume is $7K across 1 active outcomes. Data sources: Kalshi. Expected resolution by Jan 1, 2033.
Leading Outcome
Before 2033
40.0%
Total Vol
$7K
Across all linked platforms
Platform
1
Kalshi only
Best Spread
0 bps
High-confidence matched line
How This Market Resolves
Live prediction market odds for "Will the FDA approve a cure for Type 1 diabetes before 2033?". Before 2033 is leading at 40.0%. Total volume is $7K across 1 active outcomes. Data sources: Kalshi. Expected resolution by Jan 1, 2033.
Expected resolution date: Jan 1, 2033.
FAQ
What does spread mean here?
Spread is the cross-platform pricing gap for the same outcome. Larger gaps can signal opportunity, but verify freshness and match quality first.
Are outcomes exactly the same across venues?
Outcomes are canonicalized and confidence-scored. Manual labels are surfaced when venue naming differs materially.
How fresh is this data?
Latest market updates on this page refresh continuously from platform snapshots and event pollers.
News Sentiment Signal
neutralConfidence speedometer for event-level media sentiment. Higher confidence means better source depth and fresher coverage.
50%
Confidence
Moderate confidence signal
Aggregate sentiment score 0.000 from 10 analyzed headlines.
Freshness: unknown · Filtered: 0 prediction-titled articles
Metric Pack A · Lean
Confidence
50%
Label
neutral
Bull/Bear
2.00x
Source Diversity
8
Metric Pack B · Balanced
Confidence
50%
Label
neutral
Bullish %
20%
Bearish %
0%
Median Age
6671h
Sources
8
Metric Pack C · Power
Confidence
50%
Label
neutral
Bullish %
20%
Bearish %
0%
Median Age
6671h
Avg Sentiment
+0.050
Neutral %
80%
Duplicate %
0%
Coverage trend: Low
Providers: google_news_rss
Latest News
Medicare's GLP-1 Coverage Expansion Leaves 3.4 Million Eligible Seniors Without Drug Access - altitudesmagazine.com
altitudesmagazine.com·2d ago·neutral
2026 Pipelines to watch - PharmaLive
PharmaLive·61d ago·neutral
Insulin Delivery Devices Market Size, Share & Growth, 2033 - marketdataforecast.com
marketdataforecast.com·135d ago·bullish
Oral Biologics Market Size, Share & Growth Report, 2033 - marketdataforecast.com
marketdataforecast.com·151d ago·bullish
Biotech Partnership to Revolutionize Diabetes Treatment - Streetwise Reports
Streetwise Reports·264d ago·neutral